Anya Biopharm Inc. (TPEX:7776)

Anya Biopharm Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Sep 18, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Market Capitalization	2,617	1,849	-	-
Enterprise Value	2,233	1,385	-	-
Last Close Price	53.30	37.65	-	-
PS Ratio	105.38	85.60	-	-
PB Ratio	6.57	3.96	-	-
P/TBV Ratio	6.67	4.00	-	-
EV/Sales Ratio	89.94	64.11	-	-
Debt / Equity Ratio	0.01	0.01	-1.24	-1.18
Asset Turnover	0.05	0.09	0.14	-
Quick Ratio	39.03	41.41	0.11	0.05
Current Ratio	39.27	41.59	0.12	0.09
Return on Equity (ROE)	-17.21%	-19.20%	-	-
Return on Assets (ROA)	-5.86%	-10.64%	-105.84%	-
Return on Capital (ROIC)	-6.09%	-10.93%	-120.87%	-
Earnings Yield	-2.87%	-2.00%	-	-
FCF Yield	-2.44%	-1.63%	-	-
Buyback Yield / Dilution	-415.67%	-1351.36%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.